(ACI) Albertsons Companies - NYSE
Sector: Consumer Defensive | Industry: Grocery Stores | Exchange: NYSE (USA) | Market Cap: 8.091m USD | Total Return: -23.6% in 12m
Avg Turnover: 86.2M
EPS Trend: -96.7%
Qual. Beats: 3
Rev. Trend: 96.5%
Qual. Beats: -1
Warnings
High Debt/EBITDA (6.4) with thin interest coverage (1.6)
Altman Z'' 0.16 < 1.0 - financial distress zone
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
Albertsons Companies, Inc. (ACI) is a prominent food and drug retailer based in Boise, Idaho, operating an extensive network of grocery stores across the United States. The company manages a multi-banner portfolio including Safeway, Vons, and Jewel-Osco, providing a mix of grocery items, pharmacy services, and fuel. Its vertically integrated business model includes private manufacturing facilities and distribution centers to support its physical and digital sales channels.
The food retail sector typically operates on thin profit margins, often between 1% and 3%, placing a high premium on supply chain efficiency and private-label brand penetration. As a mature industry participant, Albertsons relies on its pharmacy and fuel segments to drive recurring foot traffic and diversify revenue streams beyond traditional food sales. Investors can explore detailed valuation metrics and peer comparisons for Albertsons on ValueRay.
Founded in 1860, the company has evolved through significant mergers and acquisitions to become one of the largest food retailers in North America. Its current operations focus on integrating digital commerce platforms with brick-and-mortar assets to compete in an increasingly omnichannel retail environment.
- FTC legal challenges to Kroger merger create significant stock price volatility
- Digital sales growth and loyalty program engagement expand retail profit margins
- Private label brand penetration increases overall gross margin and consumer retention
- Pharmacy service expansion and vaccine demand drive consistent high-margin foot traffic
- Inflationary pressures on food prices impact consumer discretionary spending and volume
| Net Income: 217.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 5.27 > 1.0 |
| NWC/Revenue: -1.33% < 20% (prev -0.86%; Δ -0.47% < -1%) |
| CFO/TA 0.15 > 3% & CFO 3.93b > Net Income 217.4m |
| Net Debt (21.9b) to EBITDA (3.42b): 6.39 < 3 |
| Current Ratio: 0.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (509.7m) vs 12m ago -12.74% < -2% |
| Gross Margin: 26.67% > 18% (prev 27.68%; Δ -1.02% > 0.5%) |
| Asset Turnover: 296.7% > 50% (prev 274.3%; Δ 22.35% > 0%) |
| Interest Coverage Ratio: 1.55 > 6 (EBIT TTM 781.7m / Interest Expense TTM 504.2m) |
| A: -0.04 (Total Current Assets 6.72b - Total Current Liabilities 7.82b) / Total Assets 26.8b |
| B: 0.05 (Retained Earnings 1.38b / Total Assets 26.8b) |
| C: 0.03 (EBIT TTM 781.7m / Avg Total Assets 28.0b) |
| D: 0.07 (Book Value of Equity 1.84b / Total Liabilities 24.9b) |
| Altman-Z'' = 0.16 = B |
| DSRI: 1.08 (Receivables 932.6m/834.8m, Revenue 83.2b/80.4b) |
| GMI: 1.04 (GM 27.68% / 26.67%) |
| AQI: 0.65 (AQ_t 0.15 / AQ_t-1 0.23) |
| SGI: 1.03 (Revenue 83.2b / 80.4b) |
| TATA: -0.14 (NI 217.4m - CFO 3.93b) / TA 26.8b) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of June 10, 2026, the stock is trading at USD 15.66 with a total of 6,972,102 shares traded.
Over the past week, the price has changed by +0.45%,
over one month by -1.63%,
over three months by -8.19% and
over the past year by -23.64%.
Albertsons Companies has received a consensus analysts rating of 3.76. Therefore, it is recommended to hold ACI.
- StrongBuy: 5
- Buy: 6
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 20.9 | 33.7% |
P/E Trailing = 40.9
P/E Forward = 7.2046
P/S = 0.0973
P/B = 4.4062
P/EG = 1.4414
Revenue TTM = 83.2b USD
EBIT TTM = 781.7m USD
EBITDA TTM = 3.42b USD
Long Term Debt = 8.41b USD (from longTermDebt, last quarter)
Short Term Debt = 1.27b USD (from shortTermDebt, last quarter)
Debt = 22.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 6.76b
Net Debt = 21.9b USD (calculated: Debt 22.1b - CCE 198.6m)
Enterprise Value = 30.0b USD (8.09b + Debt 22.1b - CCE 198.6m)
Interest Coverage Ratio = 1.55 (Ebit TTM 781.7m / Interest Expense TTM 504.2m)
EV/FCF = 14.30x (Enterprise Value 30.0b / FCF TTM 2.09b)
FCF Yield = 6.99% (FCF TTM 2.09b / Enterprise Value 30.0b)
FCF Margin = 2.52% (FCF TTM 2.09b / Revenue TTM 83.2b)
Net Margin = 0.26% (Net Income TTM 217.4m / Revenue TTM 83.2b)
Gross Margin = 26.67% ((Revenue TTM 83.2b - Cost of Revenue TTM 61.0b) / Revenue TTM)
Gross Margin QoQ = 25.11% (prev 27.45%)
Tobins Q-Ratio = 1.12 (Enterprise Value 30.0b / Total Assets 26.8b)
Interest Expense / Debt = 2.29% (Interest Expense 504.2m / Debt 22.1b)
Taxrate = 18.82% (50.4m / 267.8m)
NOPAT = 634.6m (EBIT 781.7m * (1 - 18.82%))
Current Ratio = 0.86 (Total Current Assets 6.72b / Total Current Liabilities 7.82b)
Debt / Equity = 12.01 (Debt 22.1b / totalStockholderEquity, last quarter 1.84b)
Debt / EBITDA = 6.39 (Net Debt 21.9b / EBITDA 3.42b)
Debt / FCF = 10.44 (Net Debt 21.9b / FCF TTM 2.09b)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.78% (Net Income 217.4m / Total Assets 26.8b)
RoE = 8.17% (Net Income TTM 217.4m / Total Stockholder Equity 2.66b)
RoCE = 7.06% (EBIT 781.7m / Capital Employed (Equity 2.66b + L.T.Debt 8.41b))
RoIC = 3.17% (NOPAT 634.6m / Invested Capital 20.0b)
WACC = 2.78% (E(8.09b)/V(30.2b) * Re(5.29%) + D(22.1b)/V(30.2b) * Rd(2.29%) * (1-Tc(0.19)))
Discount Rate = 5.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -40.45 | Cagr: -5.66%
[DCF] Terminal Value 77.97% ; FCFF base≈1.56b ; Y1≈1.78b ; Y5≈2.63b
[DCF] Fair Price = 35.70 (EV 39.5b - Net Debt 21.9b = Equity 17.7b / Shares 494.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -96.66 | EPS CAGR: -15.90% | SUE: 1.47 | # QB: 3
Revenue Correlation: 96.50 | Revenue CAGR: 1.87% | SUE: -0.94 | # QB: -1
EPS current Quarter (2026-08-31): EPS=0.46 | Chg30d=-0.24% | Revisions=-20% | Analysts=18
EPS current Year (2027-02-28): EPS=2.29 | Chg30d=-0.03% | Revisions=-20% | GrowthEPS=+4.9% | GrowthRev=-0.9%
EPS next Year (2028-02-29): EPS=2.46 | Chg30d=+0.05% | Revisions=+20% | GrowthEPS=+7.7% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: -20%